Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule.

PubWeight™: 1.65‹?› | Rank: Top 3%

🔗 View Article (PMC 1356985)

Published in Ann Surg on March 01, 2005

Authors

Eric Rullier1, Christophe Laurent, Frédéric Bretagnol, Anne Rullier, Véronique Vendrely, Frank Zerbib

Author Affiliations

1: Department of Surgery, Saint-André Hospital, Bordeaux, France. eric.rullier@chu-bordeaux.fr

Associated clinical trials:

Optical Biopsy for Distal Margin in Low Rectal Cancer | NCT04016948

PRP Injection Into Anal Sphincters for Fecal Incontinence | NCT04063293

Articles citing this

Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview. Int J Colorectal Dis (2011) 1.35

Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol (2010) 1.24

Oncologic outcome of intersphincteric resection for very low rectal cancer. World J Surg (2009) 1.10

Laparoscopic transanal abdominal transanal resection with sphincter preservation for rectal cancer in the distal 3 cm of the rectum after neoadjuvant therapy. Surg Endosc (2010) 1.06

Intersphincteric resection for very low rectal cancer: a systematic review. Surg Today (2012) 1.04

Laparoscopic intersphincteric resection for low rectal cancer. World J Surg (2011) 1.03

A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg (2007) 1.02

Short-term clinical outcome of robot-assisted intersphincteric resection for low rectal cancer: a retrospective comparison with conventional laparoscopy. Surg Endosc (2012) 1.01

Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Colorectal Dis (2007) 0.99

Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc (2015) 0.93

Evaluation of selective defunctioning stoma after low anterior resection for rectal cancer. Int J Colorectal Dis (2007) 0.92

Bladder-sparing extended resection of locally advanced rectal cancer involving the prostate and seminal vesicles. Surg Today (2007) 0.92

An ontogenetic approach to gynecologic malignancies. Insights Imaging (2016) 0.91

Neoadjuvant therapy followed by local excision and two-stage total mesorectal excision: a new strategy for sphincter preservation in locally advanced ultra-low rectal cancer. Gastroenterol Rep (Oxf) (2014) 0.88

Clinical significance of magnetic resonance imaging findings in rectal cancer. World J Radiol (2011) 0.86

Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc (2011) 0.86

Short-term outcomes of laparoscopic intersphincteric resection from a phase II trial to evaluate laparoscopic surgery for stage 0/I rectal cancer: Japan Society of Laparoscopic Colorectal Surgery Lap RC. Surg Endosc (2012) 0.86

Sphincter-sparing surgery for adenocarcinoma of the distal 3 cm of the true rectum: results after neoadjuvant therapy and minimally invasive radical surgery or local excision. Surg Endosc (2013) 0.85

Laparoscopic and converted approaches to rectal cancer resection have superior long-term outcomes: a comparative study by operative approach. Surg Endosc (2014) 0.84

Risk factors for adverse outcome in low rectal cancer. World J Gastroenterol (2012) 0.83

Completely abdominal intersphincteric resection for lower rectal cancer: feasibility and comparison of robot-assisted and open surgery. Surg Endosc (2014) 0.83

Clinical outcome of intersphincteric resection for ultra-low rectal cancer. World J Gastroenterol (2006) 0.82

Low-lying rectal cancer with anal canal involvement: abdominoperineal or low anterior resection after neoadjuvant chemoradiotherapy. Gastrointest Cancer Res (2011) 0.82

Preoperative evaluation of the depth of anal canal invasion in very low rectal cancer by magnetic resonance imaging and surgical indications for intersphincteric resection. Surg Today (2011) 0.82

Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer. Surg Today (2013) 0.81

10-Year Oncologic Outcomes After Laparoscopic or Open Total Mesorectal Excision for Rectal Cancer. World J Surg (2016) 0.81

Differences in tissue degeneration between preoperative chemotherapy and preoperative chemoradiotherapy for colorectal cancer. Int J Colorectal Dis (2012) 0.81

Perspectives on the treatment of colorectal carcinoma. World J Gastrointest Oncol (2010) 0.80

Does anastomotic leakage impair functional results and quality of life after laparoscopic sphincter-saving total mesorectal excision for rectal cancer? A case-matched study. Int J Colorectal Dis (2014) 0.80

Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial. World J Surg Oncol (2009) 0.79

Real-time optical diagnosis for surgical margin in low rectal cancer using multiphoton microscopy. Surg Endosc (2013) 0.79

Sphincter-sparing resection for rectal cancer. Clin Colon Rectal Surg (2007) 0.79

Redo-surgery by transanal colonic pull-through for failed anastomosis associated with chronic pelvic sepsis or rectovaginal fistula. Int J Colorectal Dis (2015) 0.78

Analysis of the clinical factors associated with anal function after intersphincteric resection for very low rectal cancer. World J Surg Oncol (2013) 0.78

Long-term results of extended intersphincteric resection for very low rectal cancer: a retrospective study. BMC Surg (2016) 0.77

Sphincter-preserving R0 total mesorectal excision with resection of internal genitalia combined with pre- or postoperative chemoradiation for T4 rectal cancer in females. World J Gastroenterol (2007) 0.77

Comparison of tumor recurrence between laparoscopic total mesorectal excision with sphincter preservation and laparoscopic abdominoperineal resection for low rectal cancer. Surg Endosc (2013) 0.77

Update and debate issues in surgical treatment of middle and low rectal cancer. J Korean Soc Coloproctol (2012) 0.77

Role of protective stoma in low anterior resection for rectal cancer: a meta-analysis. World J Gastroenterol (2014) 0.77

Intersphincteric resection and coloanal anastomosis in treatment of distal rectal cancer. Int J Surg Oncol (2012) 0.76

Role of intraoperative frozen section for assessing distal resection margin after anterior resection. Int J Colorectal Dis (2015) 0.76

Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questions. Int J Colorectal Dis (2007) 0.76

Pouch operation for rectal cancer. Surg Today (2010) 0.75

Hospital variation in sphincter preservation for elderly rectal cancer patients. J Surg Res (2014) 0.75

Survival after Abdominoperineal and Sphincter-Preserving Resection in Nonmetastatic Rectal Cancer: A Population-Based Time-Trend and Propensity Score-Matched SEER Analysis. Gastroenterol Res Pract (2017) 0.75

The use of laparoscopic surgery in the treatment of rectal cancer. J Med Life (2011) 0.75

Progress in rectal cancer treatment. ISRN Gastroenterol (2012) 0.75

Intersphincteric resection for low rectal cancer: an overview. Int J Surg Oncol (2012) 0.75

Laparoscopic Low Anterior Resection and Eversion Technique Combined With a Nondog Ear Anastomosis for Mid- and Distal Rectal Neoplasms: A Preliminary and Feasibility Study. Medicine (Baltimore) (2015) 0.75

Sphincter saving resection: end of the 2 cm rule? Ann Surg (2005) 0.75

Efficacy of an additional flap operation in bladder-preserving surgery with radical prostatectomy and cystourethral anastomosis for rectal cancer involving the prostate. Surg Today (2017) 0.75

Comparison of the clinical results of abdominoperanal intersphincteric resection and abdominoperineal resection for lower rectal cancer. Int J Colorectal Dis (2017) 0.75

Necessary circumferential resection margins to prevent rectal cancer relapse after abdomino-peranal (intersphincteric) resection. Langenbecks Arch Surg (2016) 0.75

Association between pathologic features of peripheral nerves and postoperative anal function after neoadjuvant therapy for low rectal cancer. Int J Colorectal Dis (2016) 0.75

Sphincter-Preserving Surgery for Low Rectal Cancers: Incidence and Risk Factors for Permanent Stoma. World J Surg (2017) 0.75

Reduced luminal circumference of tumors plays a key role in anorectal function during the early period after neoadjuvant chemoradiation therapy in rectal cancer patients. Int J Colorectal Dis (2015) 0.75

Articles cited by this

Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07

Local recurrences after sphincter saving excisions for carcinoma of the rectum and rectosigmoid. Br J Surg (1951) 4.85

Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg (1998) 4.56

Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg (2002) 2.89

Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys (2003) 2.38

Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17

Intersphincteric resection for low rectal tumours. Br J Surg (1994) 1.85

Intersphincteric resection with excision of internal anal sphincter for conservative treatment of very low rectal cancer. Dis Colon Rectum (1999) 1.83

Per anum intersphincteric rectal dissection with direct coloanal anastomosis for lower rectal cancer: the ultimate sphincter-preserving operation. Dis Colon Rectum (1997) 1.76

The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg (1983) 1.63

Definition of local recurrence after surgery for rectal carcinoma. Br J Surg (1995) 1.59

Residual tumor (R) classification and prognosis. Semin Surg Oncol (1994) 1.51

Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg (2001) 1.43

Impact of total mesorectal excision on the results of surgery of distal rectal cancer. Br J Surg (2001) 1.25

Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys (1998) 1.20

Sphincter-saving operations for cancer of the rectum. N Engl J Med (1979) 1.20

Intersphincteric excision of the rectum. Br J Surg (1977) 1.19

Long-term results of low anterior resection with intersphincteric anastomosis in carcinoma of the lower one-third of the rectum: analysis of 31 patients. Dis Colon Rectum (2000) 1.17

Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results. Ann Surg (1995) 1.15

Comparison of functional results and quality of life between intersphincteric resection and conventional coloanal anastomosis for low rectal cancer. Dis Colon Rectum (2004) 1.11

Laparoscopic intersphincteric resection with coloplasty and coloanal anastomosis for mid and low rectal cancer. Br J Surg (2003) 1.07

The length of the anal canal. Dis Colon Rectum (1982) 1.03

Treatment of non-disseminated cancer of the lower rectum. Br J Surg (1996) 1.02

Anatomic and physiologic measurements of the internal and external anal sphincters in normal females. Obstet Gynecol (1998) 0.95

Adenocarcinoma of the lower third of the rectum surgically treated with a <10-MM distal clearance: preliminary results in 35 N0 patients. Ann Surg Oncol (2001) 0.95

Fecal continence following partial resection of the anal canal in distal rectal cancer: long-term results after coloanal anastomoses. Surgery (2000) 0.92

Options for sphincter preservation in surgery for low rectal cancer. Br J Surg (2003) 0.88

Prediction of local recurrence and survival of carcinoma of the rectum by surgical and histopathological assessment of local clearance. Br J Surg (1995) 0.83

Recent advances in the surgical treatment of faecal incontinence. Br J Surg (1998) 0.80

Articles by these authors

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol (2010) 7.29

Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology (2006) 5.46

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet (2012) 5.12

Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology (2007) 3.18

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun (2013) 3.06

Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology (2009) 2.20

Segmental reversal of the small bowel can end permanent parenteral nutrition dependency: an experience of 38 adults with short bowel syndrome. Ann Surg (2012) 2.01

Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol (2008) 1.98

Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry. Med Phys (2009) 1.87

Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol (2012) 1.74

Laparoscopic colorectal surgery in elderly patients: a matched case-control study in 178 patients. J Am Coll Surg (2007) 1.73

Real-time MR temperature mapping of rabbit liver in vivo during thermal ablation. Magn Reson Med (2003) 1.62

Management and prognosis of metastases to the thyroid gland. J Am Coll Surg (2005) 1.60

Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology (2008) 1.58

An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment. Eur J Radiol (2012) 1.51

Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut (2012) 1.48

Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis (2008) 1.39

[Di-Antalvic-induced esophageal ulcer]. Gastroenterol Clin Biol (2003) 1.39

Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma. Infect Immun (2004) 1.30

Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology (2003) 1.22

Evaluation of liver tumors using acoustic radiation force impulse elastography and correlation with histologic data. J Ultrasound Med (2013) 1.21

Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg (2010) 1.18

Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg (2004) 1.17

Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int (2008) 1.17

International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems. Hum Pathol (2012) 1.16

Low rectal cancer: classification and standardization of surgery. Dis Colon Rectum (2013) 1.16

Perineal transanal approach: a new standard for laparoscopic sphincter-saving resection in low rectal cancer, a randomized trial. Ann Surg (2014) 1.14

Hepatocellular adenoma: what is new in 2008. Hepatol Int (2008) 1.12

Comparison of functional results and quality of life between intersphincteric resection and conventional coloanal anastomosis for low rectal cancer. Dis Colon Rectum (2004) 1.11

Impact of complex Crohn's disease on the outcome of laparoscopic ileocecal resection: a comparative clinical study in 124 patients. Dis Colon Rectum (2009) 1.10

Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis (2010) 1.10

Non-invasive determination of tissue thermal parameters from high intensity focused ultrasound treatment monitored by volumetric MRI thermometry. NMR Biomed (2009) 1.08

Validation of the French version of the Fecal Incontinence Quality-of-Life (FIQL) scale. Gastroenterol Clin Biol (2004) 1.05

The Chicago classification for achalasia in a French multicentric cohort. Dig Liver Dis (2012) 1.04

Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma. J Clin Oncol (2012) 1.02

Real-time volumetric MRI thermometry of focused ultrasound ablation in vivo: a feasibility study in pig liver and kidney. NMR Biomed (2010) 1.01

Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter (2013) 1.01

Gram-scale CCVD synthesis of double-walled carbon nanotubes. Chem Commun (Camb) (2003) 1.00

FNH-like nodules: Possible precursor lesions in patients with focal nodular hyperplasia (FNH). Comp Hepatol (2003) 0.98

Comparison of quality of life and anorectal function after artificial sphincter implantation. Dis Colon Rectum (2002) 0.98

The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers. Nutr J (2007) 0.96

Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. J Am Coll Surg (2006) 0.95

Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activity. J Hepatol (2006) 0.94

Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study. World J Gastroenterol (2006) 0.93

Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis. Inflamm Bowel Dis (2007) 0.93

Selective portal vein ligation and embolization induce different tumoral responses in the rat liver. Surgery (2010) 0.93

A second liver resection due to recurrent colorectal liver metastases. Arch Surg (2007) 0.93

Safety, feasibility, and short-term outcomes of single port access colorectal surgery: a single institutional case-matched study. J Gastrointest Surg (2011) 0.92

Outcomes of laparoscopic colorectal surgery in obese and nonobese patients: a case-matched study of 180 patients. Am J Surg (2009) 0.91

Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J Am Coll Surg (2005) 0.90

Two-dimensional blue native/SDS gel electrophoresis of multiprotein complexes from Helicobacter pylori. Mol Cell Proteomics (2006) 0.90

Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index. Am J Pathol (2003) 0.89

Risk factors for fecal incontinence after intersphincteric resection for rectal cancer. Dis Colon Rectum (2011) 0.89

Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma. Am J Surg Pathol (2010) 0.88

Total laparoscopic ileal pouch-anal anastomosis: prospective series of 82 patients. Surg Endosc (2008) 0.88

Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study. J Hepatol (2010) 0.87

Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition. Neoplasia (2006) 0.87

Pathological grading of regression: an International Study Group perspective. J Clin Pathol (2012) 0.87

Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas. Hum Pathol (2011) 0.86

Predictors of response to infliximab in luminal Crohn's disease. Gastroenterol Clin Biol (2005) 0.86

Multiple organ failure as initial presentation of pheochromytoma. Am J Emerg Med (2005) 0.86

Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma. Am J Surg Pathol (2005) 0.86

Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. Ann Surg Oncol (2012) 0.86

Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey. Clin Drug Investig (2011) 0.85

[Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab): results of a multicentric and retrospective study]. Gastroenterol Clin Biol (2002) 0.85

The identification of small nodules in liver adenomatosis. J Hepatol (2003) 0.85

Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer. BMC Cancer (2011) 0.85

"Surgeons' intuition" versus "prognostic models": predicting the risk of liver resections. Ann Surg (2014) 0.83

Perihilar cholangiocarcinoma, the need for a new staging system. Clin Res Hepatol Gastroenterol (2011) 0.83

Relevance of postoperative peak transaminase after elective hepatectomy. Ann Surg (2014) 0.82

Endotherapy for and tailored approaches to treating GERD, and refractory GERD. Ann N Y Acad Sci (2013) 0.82

Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy. Radiology (2014) 0.81

Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context. Int J Hepatol (2013) 0.81

The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy. HPB (Oxford) (2012) 0.81

Obesity as a risk factor for hepatocellular carcinoma in a noncirrhotic patient. Semin Liver Dis (2004) 0.81

[Patient-doctor relationship in the irritable bowel syndrome. Results of a French prospective study on the influence of the functional origin of the complaints]. Gastroenterol Clin Biol (2002) 0.81

Evaluation of the homologous recombination in Helicobacter pylori. Helicobacter (2005) 0.80

Laparoscopic surgery for rectal cancer: preoperative radiochemotherapy versus surgery alone. Surg Endosc (2012) 0.80

Laparoscopic total mesorectal excision with coloanal anastomosis for rectal cancer. Ann Surg (2015) 0.80

A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation. Virchows Arch (2012) 0.80

Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapy. Gastroenterol Clin Biol (2006) 0.80

Functional testing: pharyngeal pH monitoring and high-resolution manometry. Ann N Y Acad Sci (2013) 0.80

A multicentre, randomised, controlled trial to assess the safety, ease of use, and reliability of hyaluronic acid/carboxymethylcellulose powder adhesion barrier versus no barrier in colorectal laparoscopic surgery. Trials (2014) 0.80

Real-time monitoring of hepatocellular carcinoma radiofrequency ablation by quantitative temperature MRI. Semin Liver Dis (2006) 0.80

The expression of the hypoxia markers CA9 and CXCR4 is correlated with survival in patients with neuroendocrine tumours of the ileum. Neuroendocrinology (2011) 0.80

Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma. Am J Surg (2013) 0.80

Primary malignant fibrous histiocytoma of the pancreas: benefit of the multidisciplinary approach. Eur J Gastroenterol Hepatol (2010) 0.79